• Thumbnail for Erlotinib
    Erlotinib, sold under the brand name Tarceva among others, is a medication used to treat non-small cell lung cancer (NSCLC) and pancreatic cancer. Specifically...
    22 KB (1,993 words) - 23:37, 23 March 2024
  • metastatic breast cancer. Erlotinib, an anti-tumor agent. Afatinib for treatment of cancers resistant to gefinitib and erlotinib. Quinazolinone Niementowski...
    14 KB (1,245 words) - 15:37, 25 October 2024
  • Thumbnail for Gefitinib
    breast, lung and other cancers. Gefitinib is an EGFR inhibitor, like erlotinib, which interrupts signaling through the epidermal growth factor receptor...
    21 KB (2,162 words) - 15:09, 19 August 2024
  • Gimatecan Irinotecan Topotecan Etoposide Teniposide Tafluposide Bortezomib Erlotinib Gefitinib Imatinib Vemurafenib Vismodegib Azacitidine Azathioprine Capecitabine...
    5 KB (324 words) - 12:07, 20 July 2024
  • Thumbnail for Targeted therapy
    Erlotinib (marketed as Tarceva). Erlotinib inhibits epidermal growth factor receptor, and works through a similar mechanism as gefitinib. Erlotinib has...
    20 KB (2,234 words) - 01:21, 22 July 2024
  • Thumbnail for Polycythemia vera
    its long-term safety. There are indications that the lung cancer drug erlotinib may be an additional treatment option for those with certain genetic markers...
    24 KB (2,684 words) - 10:59, 5 June 2024
  • Thumbnail for Ectropion
    Mechanical Allergic Facial nerve palsy Anti-cancer treatments such as erlotinib, cetuximab, and panitumumab, which block the function of EGFR (the epidermal...
    3 KB (220 words) - 20:32, 27 August 2024
  • Thumbnail for Afatinib
    mutations targeted by first generation tyrosine-kinase inhibitors (TKIs) like erlotinib or gefitinib, but also against less common mutations which are resistant...
    15 KB (1,122 words) - 15:16, 4 August 2024
  • Thumbnail for Skin care
    Nicolson M, Groves RW, et al. (2009). "Expert consensus on the management of erlotinib-associated cutaneous toxicity in the U.K." Oncologist. 14 (8): 840–7....
    22 KB (2,163 words) - 05:09, 21 October 2024
  • Thumbnail for Osimertinib
    treatment with other EGFR tyrosine kinase inhibitors, such as gefitinib, erlotinib, and afatinib. In the US, EGFR exon 19 deletions, exon 21 L858R mutations...
    18 KB (1,573 words) - 05:19, 15 October 2024
  • Thumbnail for KRAS
    antagonists such as erlotinib (Tarceva) or gefitinib (Iressa). Patients who harbor an EGFR mutation have a 60% response rate to erlotinib. However, the mutation...
    45 KB (5,079 words) - 12:00, 23 October 2024
  • Thumbnail for Lung cancer
    inhibitors osimertinib, erlotinib, gefitinib, afatinib, or dacomitinib – with osimertinib known to be superior to erlotinib and gefitinib, and all superior...
    90 KB (9,784 words) - 07:53, 10 October 2024
  • Thumbnail for Epidermal growth factor receptor
    against EGFR (called "EGFR inhibitors", EGFRi), including gefitinib, erlotinib, afatinib, brigatinib and icotinib for lung cancer, and cetuximab for...
    60 KB (6,879 words) - 14:26, 16 July 2024
  • Thumbnail for Roche
    (oseltamivir), for influenza A and B (both treatment and prevention). Tarceva (erlotinib), for various cancers. Tasmar (tolcapone), for parkinson's disease, licensed...
    57 KB (5,180 words) - 21:47, 26 September 2024
  • Thumbnail for Pancreatic cancer
    However, the combination of gemcitabine with erlotinib was found to increase survival modestly, and erlotinib was licensed by the FDA for use in pancreatic...
    122 KB (12,840 words) - 02:36, 19 October 2024
  • Thumbnail for Dehydroepiandrosterone
    Kinase inhibitors: Afatinib Agerafenib Brigatinib Canertinib Dacomitinib Erlotinib Gefitinib Grandinin Icotinib Lapatinib Neratinib Osimertinib Vandetanib...
    42 KB (3,935 words) - 20:28, 27 October 2024
  • Thumbnail for Dexamethasone
    Kinase inhibitors: Afatinib Agerafenib Brigatinib Canertinib Dacomitinib Erlotinib Gefitinib Grandinin Icotinib Lapatinib Neratinib Osimertinib Vandetanib...
    68 KB (5,999 words) - 00:04, 25 October 2024
  • Thumbnail for Cryptogenic organizing pneumonia
    infection by bacteria, viruses and parasites Drugs: antineoplastic drugs, erlotinib, amiodarone Chemical exposure, most notably to diacetyl Vaping: On October...
    21 KB (2,126 words) - 05:25, 12 August 2024
  • Thumbnail for CYP3A4
    chemotherapeutics: docetaxel, tamoxifen, paclitaxel, cyclophosphamide, doxorubicin, erlotinib, etoposide, ifosfamide, teniposide, vinblastine, vincristine, vindesine...
    80 KB (7,794 words) - 21:26, 15 July 2024
  • Thumbnail for Tyrosine kinase inhibitor
    developed against chronic myelogenous leukemia (CML) and later gefitinib and erlotinib aiming at the EGF receptor. Dasatinib is a Src tyrosine kinase inhibitor...
    10 KB (1,179 words) - 18:31, 8 August 2024
  • Thumbnail for Astellas Pharma
    (eczema) Symoron (methadone HCL) – Opioid replacement therapy Tarceva (erlotinib) – Non-small cell lung cancer and pancreatic cancer – marketed with Hoffmann-La...
    27 KB (2,460 words) - 00:25, 13 September 2024
  • Thumbnail for Amitriptyline
    Kinase inhibitors: Afatinib Agerafenib Brigatinib Canertinib Dacomitinib Erlotinib Gefitinib Grandinin Icotinib Lapatinib Neratinib Osimertinib Vandetanib...
    92 KB (8,729 words) - 03:44, 26 October 2024
  • molecular signature. In addition, the test appeared to be predictive of erlotinib impact on survival, as only "VeriStrat Good patients" benefited from such...
    2 KB (282 words) - 18:47, 14 August 2023
  • BRAF inhibitors sorafenib, vemurafenib -tinib Tyrosine-kinase inhibitors erlotinib, crizotinib -zomib proteasome inhibitors bortezomib, carfilzomib -vastatin...
    26 KB (2,150 words) - 12:06, 11 September 2024
  • Thumbnail for Insulin
    Kinase inhibitors: Afatinib Agerafenib Brigatinib Canertinib Dacomitinib Erlotinib Gefitinib Grandinin Icotinib Lapatinib Neratinib Osimertinib Vandetanib...
    121 KB (13,799 words) - 18:53, 22 October 2024
  • Thumbnail for Cholangiocarcinoma
    pilot study suggested possible benefit from the tyrosine kinase inhibitor erlotinib in people with advanced cholangiocarcinoma. Radiation therapy appears...
    74 KB (7,649 words) - 05:26, 16 August 2024
  • Double-Blind Phase III Study of Onartuzumab (MetMAb) in Combination With Erlotinib Versus Erlotinib Alone in Patients Who Have Received Standard Chemotherapy for...
    5 KB (424 words) - 21:59, 10 July 2021
  • Thumbnail for Non-small-cell lung cancer
    block the EGFR protein known as tyrosine kinase inhibitors specifically, erlotinib, gefitinib, afatinib, or osimertinib. Reliable identification of mutations...
    51 KB (5,333 words) - 22:13, 7 September 2024
  • carcinoma of the head and neck" "Efficacy of bevacizumab plus erlotinib versus erlotinib alone in advanced non-small-cell lung cancer after failure of...
    12 KB (1,334 words) - 02:23, 28 November 2023
  • cancer treatment was subsequently revoked in November 2011. 2004: Tarceva (erlotinib): Treatment for patients with locally advanced or metastatic non-small...
    32 KB (2,865 words) - 04:21, 4 October 2024